Hanns J Rziha

Title: Hanns J Rziha: Innovator in Pseudorabies Virus Vaccines

Introduction

Hanns J Rziha is a notable inventor based in Tubingen, Germany. He has made significant contributions to the field of virology, particularly in the development of vaccines for the pseudorabies virus (PRV). With a total of 2 patents, Rziha's work has been instrumental in advancing vaccine technology.

Latest Patents

Rziha's latest patents focus on innovative approaches to pseudorabies virus vaccines. One of his patents involves DNA encoding amino acids 590-710 of glycoprotein gII of pseudorabies. This invention concerns a PRV vaccine comprising a polypeptide of the PRV glycoprotein gII or a fragment thereof, which has been shown to be the site of interaction for PRV neutralizing antibodies. Additionally, vector vaccines capable of expressing a polynucleotide fragment coding for such a polypeptide are also part of this invention. Another patent similarly addresses the pseudorabies virus vaccine, emphasizing the importance of the glycoprotein gII in vaccine efficacy.

Career Highlights

Hanns J Rziha is associated with Akzo N.V., where he continues to contribute to research and development in vaccine technology. His work has garnered attention in the scientific community for its potential impact on animal health and disease prevention.

Collaborations

Rziha has collaborated with esteemed colleagues such as Christa S Schreurs and Thomas C Mettenleiter. These collaborations have further enriched his research and have led to advancements in the understanding of pseudorabies virus and its vaccines.

Conclusion

Hanns J Rziha's innovative work in the field of pseudorabies virus vaccines highlights his significant contributions to virology. His patents reflect a commitment to improving vaccine technology and animal health.